| Dr Jeffrey Y Wong, DDS | |
|
200 Brown Rd Ste 202, Fremont, CA 94539-7957 | |
| (510) 490-0591 | |
| Not Available |
| Full Name | Dr Jeffrey Y Wong |
|---|---|
| Gender | Male |
| Speciality | Dentist - Orthodontics And Dentofacial Orthopedics |
| Location | 200 Brown Rd Ste 202, Fremont, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013184498 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223X0400X | Dentist - Orthodontics And Dentofacial Orthopedics | 30131 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Y Wong, DDS 200 Brown Rd Ste 202, Fremont, CA 94539-7957 Ph: (510) 490-0591 | Dr Jeffrey Y Wong, DDS 200 Brown Rd Ste 202, Fremont, CA 94539-7957 Ph: (510) 490-0591 |
News Archive
Peregrine Pharmaceuticals, Inc. has reported that two preclinical studies presented during the AACR 100th Annual Meeting 2009 provided further confirmation of the immunomodulatory mechanisms contributing to the anti-tumor activity of its phosphatidylserine (PS) targeting antibodies.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company's EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.
The brain continues to put up a fight even as neurodegenerative diseases like dementia damage certain areas and functions. In fact, recent findings in a Baycrest-University of Arizona study suggest that one method the brain uses to counter these diseases is the reassigning of tasks to different regions.
Researchers have found that nafamostat mesylate, when injected in the nasal cavity of Syrian hamsters, can decrease initial SARS-CoV-2 viral loads in their nose. However, this effect was temporary and further testing is required to determine clinically significant effects. The research group's findings are available on the preprint server bioRxiv*.
Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium's lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia.
› Verified 6 days ago
Dr. Kinjal Patel, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 48087 Purpleleaf St, Fremont, CA 94539 Phone: 510-651-9474 | |
Dr. Lowell Thomas, DMD Dentist Medicare: Medicare Enrolled Practice Location: 46923 Warm Springs Blvd Ste 209, Fremont, CA 94539 Phone: 510-490-5578 | |
Aaron Sanchez, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2243 Mowry Ave Ste B, Fremont, CA 94538 Phone: 510-797-8991 | |
Punam Patel, Dentist Medicare: Not Enrolled in Medicare Practice Location: 46921 Warm Springs Blvd Ste 203, Fremont, CA 94539 Phone: 510-792-7888 | |
Dr. Howard Chun-cheung Tsui, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 38050 Martha Ave, Fremont, CA 94536 Phone: 510-429-9888 | |
Dr. Matthew Moore Hansen, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 46592 Mission Blvd, Fremont, CA 94539 Phone: 510-490-3737 Fax: 510-490-1439 | |
Dr. Archana Gulati, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 39200 Liberty St, Suite D, Fremont, CA 94538 Phone: 510-797-9711 Fax: 510-797-9727 |